Heterogeneous nuclear ribonucleoprotein Q is a novel substrate of SH2 domain-containing phosphatase-2

Journal of Biochemistry

Volumn 154, Issue 5, 2013, Pages 475-480

  Watanabe, Norifumi ^a   Kato, Takayuki ^a   Fujita, Hisakazu ^a   Kitagawa, Seiichi ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Heterogeneous nuclear ribonucleoproteinQ; Pervanadate; SH2 domain containing phosphatase 2

Indexed keywords

HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN Q; PROTEIN TYROSINE PHOSPHATASE SHP 2; UNCLASSIFIED DRUG;

ARTICLE; BLOOD; CELL ACTIVATION; CELL STRAIN HL 60; CONTROLLED STUDY; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA CELL LINE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MONONUCLEAR CELL; PROTEIN ANALYSIS; PROTEIN DEPHOSPHORYLATION; PROTEIN PHOSPHORYLATION; RNA METABOLISM;

EID: 84890451693     PISSN: 0021924X     EISSN: 17562651     Source Type: Journal    
DOI: 10.1093/jb/mvt078     Document Type: Article

References (30)

1. Neel, B.G., Gu, H., and Pao, L. (2003) The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling. Trends Biochem. Sci. 28, 284-293
2. Hof, P., Pluskey, S., Dhe-Paganon, S., Eck, M.J., and Shoelson, S.E. (1998) Crystal structure of the tyrosine phosphatase SHP-2. Cell 92, 441-450
3. Matozaki, T., Murata, Y., Saito, Y., Okazawa, H., and Ohnishi, H. (2009) Protein tyrosine phosphatase SHP-2: A proto-oncogene product that promotes Ras activation. Cancer Sci. 100, 1786-1793
4. Aceto, N., Sausgruber, N., Brinkhaus, H., Gaidatzis, D., Martiny-Baron, G., Mazzarol, G., Confalonieri, S., Quarto, M., Hu, G., Balwierz, P.J., Pachkov, M., Elledge, S.J., van Nimwegen, E., Stadler, M.B., and Bentires-Alj, M. (2012) Tyrosine phosphatase SHP2 promotes breast cancer progression and maintains tumor-initiating cells via activation of key transcription factors and a positive feedback signaling loop. Nat. Med. 18, 529-537
5. Chan, R.J., Johnson, S.A., Li, Y., Yoder, M.C., and Feng, G.S. (2003) A definitive role of Shp-2 tyrosine phosphatase in mediating embryonic stem cell differentiation and hematopoiesis. Blood 102, 2074-2080
6. Xu, D. and Qu, C.K. (2008) Protein tyrosine phosphatases in the JAK/STAT pathway. Front. Biosci. 13, 4925-4932
7. Li, L., Modi, H., McDonald, T., Rossi, J., Yee, J.K., and Bhatia, R. (2011) A critical role for SHP2 in STAT5 activation and growth factor-mediated proliferation, survival, and differentiation of human CD34 cells. Blood 118, 1504-1515
8. Konieczna, I., Horvath, E., Wang, H., Lindsey, S., Saberwal, G., Bei, L., Huang, W., Platanias, L., and Eklund, E.A. (2008) Constitutive activation of SHP2 in mice cooperates with ICSBP deficiency to accelerate progression to acute myeloid leukemia. J. Clin. Invest. 118, 853-867
9. Agazie, Y.M. and Hayman, M.J. (2003) Molecular mechanism for a role of SHP2 in epidermal growth factor receptor signaling. Mol. Cell Biol. 23, 7875-7886
10. Hanafusa, H., Torii, S., Yasunaga, T., Matsumoto, K., and Nishida, E. (2004) Shp2, an SH2-containing proteintyrosine phosphatase, positively regulates receptor tyrosine kinase signaling by dephosphorylating and inactivating the inhibitor Sprouty. J. Biol. Chem. 279, 22992-22995
11. Kontaridis, M.I., Eminaga, S., Fornaro, M., Zito, C.I., Sordella, R., Settleman, J., and Bennett, A.M. (2004) SHP-2 positively regulates myogenesis by coupling to the Rho GTPase signaling pathway. Mol. Cell Biol. 24, 5340-5352
12. Kolli, S., Zito, C.I., Mossink, M.H., Wiemer, E.A., and Bennett, A.M. (2004) The major vault protein is a novel substrate for the tyrosine phosphatase SHP-2 and scaffold protein in epidermal growth factor signaling. J. Biol. Chem. 279, 29374-29385
13. Loh, M.L., Vattikuti, S., Schubbert, S., Reynolds, M.G., Carlson, E., Lieuw, K.H., Cheng, J.W., Lee, C.M., Stokoe, D., Bonifas, J.M., Curtiss, N.P., Gotlib, J., Meshinchi, S., Le Beau, M.M., Emanuel, P.D., and Shannon, K.M. (2004) Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis. Blood 103, 2325-2331
14. Tartaglia, M., Martinelli, S., Iavarone, I., Cazzaniga, G., Spinelli, M., Giarin, E., Petrangeli, V., Carta, C., Masetti, R., Aricò, M., Locatelli, F., Basso, G., Sorcini, M., Pession, A., and Biondi, A. (2005) Somatic PTPN11 mutations in childhood acute myeloid leukaemia. Br. J. Haematol. 129, 333-339
15. Tartaglia, M., Niemeyer, C.M., Fragale, A., Song, X., Buechner, J., Jung, A., Ha hlen, K., Hasle, H., Licht, J.D., and Gelb, B.D. (2003) Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. Nat. Genet. 34, 148-150
16. Bentires-Alj, M., Paez, J.G., David, F.S., Keilhack, H., Halmos, B., Naoki, K., Maris, J.M., Richardson, A., Bardelli, A., Sugarbaker, D.J., Richards, W.G., Du, J., Girard, L., Minna, J.D., Loh, M.L., Fisher, D.E., Velculescu, V.E., Vogelstein, B., Meyerson, M., Sellers, W.R., and Neel, B.G. (2004) Activating mutations of the Noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia. Cancer Res. 64, 8816-8820
17. Loh, M.L., Reynolds, M.G., Vattikuti, S., Gerbing, R.B., Alonzo, T.A., Carlson, E., Cheng, J.W., Lee, C.M., Lange, B.J., and Meshinchi, S., and Children's Cancer Group. (2004) PTPN11 mutations in pediatric patients with acute myeloid leukemia: Results from the Children's Cancer Group. Leukemia 18, 1831-1834
18. Tartaglia, M., Mehler, E.L., Goldberg, R., Zampino, G., Brunner, H.G., Kremer, H., van der Burgt, I., Crosby, A.H., Ion, A., Jeffery, S., Kalidas, K., Patton, M.A., Kucherlapati, R.S., and Gelb, B.D. (2001) Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat. Genet. 29, 465-468; Erratum in: (2001) Nat. Genet. 29, 491; (2002) Nat. Genet. 30, 123
19. Digilio, M.C., Conti, E., Sarkozy, A., Mingarelli, R., Dottorini, T., Marino, B., Pizzuti, A., and Dallapiccola, B. (2002) Grouping of multiple-lentigines/LEOPARD and Noonan syndromes on the PTPN11 gene. Am. J. Hum. Genet. 71, 389-394
20. Lacalle, R.A., Mira, E., Gomez-Mouton, C., Jimenez- Baranda, S., Martinez-A, C., and Manes, S. (2002) Specific SHP-2 partitioning in raft domains triggers integrin-mediated signaling via Rho activation. J. Cell Biol 157, 277-289
21. Mourelatos, Z., Abel, L., Yong, J., Kataoka, N., and Dreyfuss, G. (2001) SMN interacts with a novel family of hnRNP and spliceosomal proteins. EMBO J. 20, 5443-5452
22. Quaresma, A.J., Bressan, G.C., Gava, L.M., Lanza, D.C., Ramos, C.H., and Kobarg, J. (2009) Human hnRNP Q re-localizes to cytoplasmic granules upon PMA, thapsigargin, arsenite and heat-shock treatments. Exp. Cell Res. 315, 968-980
23. Weidensdorfer, D., Sto hr, N., Baude, A., Lederer, M., Ko hn, M., Schierhorn, A., Buchmeier, S., Wahle, E., and Hu ttelmaier, S. (2009) Control of c-myc mRNA stability by IGF2BP1-associated cytoplasmic RNPs. RNA 15, 104-115
24. Kitagawa, S., Takaku, F., and Sakamoto, S. (1980) Evidence that proteases are involved in superoxide production by human polymorphonuclear leukocytes and monocytes. J. Clin. Invest. 65, 74-81
25. Kato, T., Sakamoto, E., Kutsuna, H., Kimura-Eto, A., Hato, F., and Kitagawa, S. (2004) Proteolytic conversion of STAT3a to STAT3g in human neutrophils: Role of granule-derived serine proteases. J. Biol. Chem. 279, 31076-31080
26. Hinsby, A.M., Olsen, J.V., Bennett, K.L., and Mann, M. (2003) Signaling initiated by overexpression of the fibroblast growth factor receptor-1 investigated by mass spectrometry. Mol. Cell. Proteomics 2, 29-36
27. http://www.phosphosite.org/proteinAction.doid2309 &showAllSitestrue (August 30, 2013, date last accessed
28. Hresko, R.C. and Mueckler, M. (2000) A novel 68-kDa adipocyte protein phosphorylated on tyrosine in response to insulin and osmotic shock. J. Biol. Chem. 275, 18114-18120
29. Hresko, R.C. and Mueckler, M. (2002) Identification of pp68 as the tyrosine-phosphorylated form of SYNCRIP/NSAP1. A cytoplasmic RNA-binding protein. J. Biol. Chem. 277, 25233-25238
30. Quaresma, A.J., Oyama, S. Jr., Barbosa, J.A., and Kobarg, J. (2006) The acidic domain of hnRNPQ (NSAP1) has structural similarity to Barstar and binds to Apobec1. Biochem. Biophys. Res. Commun. 350, 288-297